Single Infusion of Cilta-Cel Yields 5-Year Progression-Free Survival in Multiple Myeloma

Source: Pharmacy Times articles

Cilta-cel shows promise as a CAR T-cell therapy, offering long-term remission for relapsed/refractory multiple myeloma patients without maintenance treatment.
Read More